Local News

Sonoma Biotherapeutics, a life sciences company developing treatments for autoimmune diseases, announced this week it raised $265…

Three epidemic or pandemic coronaviruses – SARS-CoV, MERS-CoV, & SARS-CoV-2 – have spilled over from…

In the wake of findings that COVID-19 virus variants are more likely to spring from…

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the…

Seattle and South San-Francisco based preclinical biotech company Sonoma Biotherapeutics has raised $265 million in…

The hallmark Alzheimer’s pathology amyloid has taken the spotlight this month, after FDA approval of…

The novel coronavirus is here to stay — that much we know. There’s still a…

When the COVID-19 pandemic hit, University of Washington scientist Deborah Fuller did a quick pivot to the…

Long before COVID-19 burst into the world, there was another viral disease that topped Dr.…

A team of neuroscientists and engineers at the Allen Institute, Princeton University and Baylor College…